Immunerelated adverse events and risk factors of carrelizumab in 528 cases of cancer patients
YU Min, LI Xin
Chinese Journal of Pharmacovigilance . 2023, (10): 1134 -1140 .  DOI: 10.19803/j.1672-8629.20230011